TIMP3 and neoplasm: MiR-21 has been shown to affect cell proliferation, invasion, and the clinical outcome by downregulating the expression of tumor suppressors, such as PDCD4 [17, 18], TIMP3 [18], RECK [19], and KRIT1 [20].